Irinotecan and temozolomide for Ewing sarcoma: The memorial sloan-kettering experience Academic Article uri icon

Overview

MeSH Major

  • Camptothecin
  • Dacarbazine
  • Sarcoma, Ewing

abstract

  • Irinotecan and temozolomide is a well-tolerated and active regimen for recurrent/progressive ES. Prospective trials are necessary to define the role of this regimen in newly diagnosed ES.

publication date

  • December 8, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/pbc.22206

PubMed ID

  • 19637327

Additional Document Info

start page

  • 1029

end page

  • 34

volume

  • 53

number

  • 6